Search for: "The Medicines Company" Results 481 - 500 of 9,211
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jul 2018, 5:15 pm by Bennett Cyphers
Many tech companies have long supported data portability as a core value. [read post]
17 May 2019, 9:19 am by Cannabis Law Group
Companies addressing concerns about employees who are current medicinal users or former recreational users may want to step lightly here. [read post]
17 Jun 2015, 6:36 pm
The series’ conclusion was, basically, that perceived problems with doctor-company ties are overblown. [read post]
18 May 2012, 6:46 pm
The next time an Insurance Company complains about the need to limit Medical Malpractice awards, they may want to ask the Florida Board of Medicine to discipline those doctors that repeatedly commit Medical Malpractice. [read post]
19 Dec 2014, 8:27 am
But, now that the legal landscape is changing and many employees are legally able to use marijuana, either for recreational or medicinal purposes, employers are going to have to change their policies. [read post]
7 Oct 2021, 10:00 pm
The Alliance for Regenerative Medicine reports that regenerative medicine and advanced therapy financing soared during the first half of 2021, resulting in the strongest half year to date, and reached 71% of 2020 full year levels. [read post]
7 Oct 2021, 10:00 pm
The Alliance for Regenerative Medicine reports that regenerative medicine and advanced therapy financing soared during the first half of 2021, resulting in the strongest half year to date, and reached 71% of 2020 full year levels. [read post]
7 Oct 2021, 10:00 pm
The Alliance for Regenerative Medicine reports that regenerative medicine and advanced therapy financing soared during the first half of 2021, resulting in the strongest half year to date, and reached 71% of 2020 full year levels. [read post]
7 Oct 2021, 10:00 pm
The Alliance for Regenerative Medicine reports that regenerative medicine and advanced therapy financing soared during the first half of 2021, resulting in the strongest half year to date, and reached 71% of 2020 full year levels. [read post]
7 Oct 2021, 10:00 pm
The Alliance for Regenerative Medicine reports that regenerative medicine and advanced therapy financing soared during the first half of 2021, resulting in the strongest half year to date, and reached 71% of 2020 full year levels. [read post]
31 Jul 2015, 2:50 pm by m zamora
In May, it recalled eight lots of the cancer medicine for the same reason.No adverse events have been reported, but a company statement on the FDA website said “administration of an intravenous product with particulate matter has the potential to result in inflammation, allergic reactions, or blockage of blood vessels, leading to tissue death, which may be life-threatening if vital organs are affected. [read post]
14 Jan 2013, 6:28 am by Mark Zamora
Even so, the company said it plans to discourage doctors from prescribing the pill based on negative findings from the trial which were announced last month. [read post]
7 Oct 2021, 10:00 pm
The Alliance for Regenerative Medicine reports that regenerative medicine and advanced therapy financing soared during the first half of 2021, resulting in the strongest half year to date, and reached 71% of 2020 full year levels. [read post]
28 Dec 2009, 8:34 pm
Marcia Angell, M.D., first woman editor-in-chief of the New England Journal of Medicine, reports that in 2002 the $35.9 billion the top drug companies earned were greater than the profits of the other 490 Fortune 500 companies combined. [read post]
13 Nov 2014, 2:16 pm by CJLF Staff
Marijuana User Sues Company Claiming Discrimination: A Rhode Island woman is suing a textile company after they refused to hire her for a two-month internship because she regularly uses 'medicinal' marijuana. [read post]
16 Sep 2008, 8:15 pm
Consumer advocates and others, including the New England Journal of Medicine, contend that such pre-emption would drastically reduce the safety of prescription drugs. [read post]
13 Apr 2011, 4:22 pm by admin
The ‘’miracles of modern medicine’ aside – it is an unfortunate reality that pharmaceutical companies tend to rush drugs to the marketplace – tending to cut corners in the trial phase of a product – in order to get it out there and making money for them. [read post]